MDL | - |
---|---|
Molecular Weight | 371.30 |
Molecular Formula | C14H17N3O9 |
SMILES | CC(OC[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](N2N=CC(NC2=O)=O)O1)=O |
Azaribine (2',3',5'-Tri-O-acetyl-6-azauridine) is a potent orotidine monophosphate decarboxylase (OMPD) inhibitor. Azaribine is an antiviral inhibitor of several RNA viruses and inhibits viral genome replication and gene transcription. Azaribine shows broad-spectrum antiviral activity ( EC 50 =3.80 nM-1.73 μM against influenza A and B viruses; EC 50 =1.62 μM against ZIKV Paraiba). Azaribine, a triacetate salt of Azauridine, has the potential for psoriasis research [1] [2] .
Azaribine (2',3',5'-Tri-O-acetyl-6-azauridine; 0-2 μM; 48 h) has cytotoxicity on MDCK cells (MTT: CC
50
=19.66 μM)
[1]
.
Azaribine shows a potent inhibitory effect on BIRFLU multiplication (MDCK cells: EC
50
=0.29 μM; A549 cells: EC
50
=0.55 μM)
[1]
.
Azaribine shows against seasonal H1N1 and H3N2 IAVs and IBV during posttreatment in MDCK cells with EC
50
of 0.60 μM, 0.77 μM, 0.80 μM
[1]
.
Azaribine is against NC H1N1 during posttreatment in 16HBE cells (EC
50
=1.58 μM)
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Cytotoxicity Assay [1]
Cell Line: | MDCK cells |
Concentration: | 0-2 μM |
Incubation Time: | 48 h |
Result: | Had cytotoxicity on MDCK cells (CC 50 =19.66 μM). |
Room temperature in continental US; may vary elsewhere.
Please store the product under the recommended conditions in the Certificate of Analysis.